7 results
Keyword Aflibercept Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Eylea
aflibercept, Wet Macular Degeneration, Macular Edema, Diabetes Complications
Date of authorisation: 21/11/2012, Revision: 17, Authorised, Last updated: 09/07/2019EMEA/H/C/002392 Eylea (aflibercept) An overview of Eylea and … contains the active substance aflibercept. How is Eylea used? Eylea … ensure the Eylea (aflibercept) EMA/481361/2018 Page … -
List item
Human medicine European public assessment report (EPAR): Zaltrap
aflibercept, Colorectal Neoplasms
Date of authorisation: 01/02/2013, Revision: 7, Authorised, Last updated: 12/10/2017Zaltrap, INN- aflibercept 30 Churchill Place … for the public Zaltrap aflibercept This is a summary of the … contains the active substance aflibercept. How is Zaltrap used? Zaltrap … -
List item
Human medicine European public assessment report (EPAR): Lonsurf
trifluridine, tipiracil hydrochloride, Colorectal Neoplasms
Date of authorisation: 25/04/2016,
, Revision: 3, Authorised, Last updated: 24/05/2019
-
List item
Human medicine European public assessment report (EPAR): Humira (updated)
adalimumab, Spondylitis, Ankylosing, Arthritis, Juvenile Rheumatoid, Uveitis, Colitis, Ulcerative, Psoriasis, Arthritis, Psoriatic, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 08/09/2003, Revision: 74, Authorised, Last updated: 16/08/2019 -
List item
Human medicine European public assessment report (EPAR): Cyramza
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014,, Revision: 7, Authorised, Last updated: 03/04/2018
-
List item
Human medicine European public assessment report (EPAR): Onzeald
etirinotecan pegol, Breast Neoplasms
Date of refusal: 08/01/2018, Refused, Last updated: 02/02/2018 -
List item
Human medicine European public assessment report (EPAR): Stivarga
regorafenib, Colorectal Neoplasms
Date of authorisation: 26/08/2013, Revision: 14, Authorised, Last updated: 08/10/2018